ClinicalTrials.gg
Sign In

Coronary Disease clinical trials

The registry lists 1,520 studies for Coronary Disease across more than 10 countries. 167 are recruiting or about to start. 828 of them are mainly about Coronary Disease (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 8 narrower conditions too, such as Coronary Artery Disease: 6,373 studies, 1,064 open.

ClinicalTrials.gov finds 34,106 studies for Coronary Disease. How that becomes 1,520 here

This page counts the studies the registry files under Coronary Disease, and those it files under no condition that list Coronary Diseasethemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 34,106Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −4,786Filed under a narrower condition, counted on its own pageCoronary Artery Disease 4,439 · Coronary Stenosis 125 · Coronary Restenosis 31 · Coronary Occlusion 28 · Coronary Aneurysm 25 · Coronary Vasospasm 20 · 2 more
  3. −22List Coronary Disease as a condition, but the registry did not file them under itMost often written as “Coronary Heart Disease Risk Reduction” (8), “Coronary Heart Disease NOS” (2), and “Non-obstructive Coronary Disease” (2). The registry filed them under other conditions only, most often Cardiovascular Diseases (9) and Heart Diseases (8).
  4. −27,778Match it another way131 name it in the title, 12 in a keyword, and 27,635 by a synonym or other text the search reads.
  5. 1,520The count on this page20 of them list Coronary Disease in their own words; the registry filed them under no condition.

Get an email when these change. Save the Coronary Disease studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
993
Status unknown
215
Recruiting
106
Active, not recruiting
58
Not yet recruiting
51
Terminated
49

Phase

Phase 4
162
Phase 3
156
Phase 2
100
Phase 1
32
Early Phase 1
9

Where

United States
274
China
221
Germany
123
United Kingdom
91
Canada
75
Italy
58

Who runs them

National Heart, Lung, and Blood Institute (NHLBI) (194) · Abbott Medical Devices (32) · China National Center for Cardiovascular Diseases (25) · Deutsches Herzzentrum Muenchen (23) · AstraZeneca (17) · Beijing Anzhen Hospital (13) · CardioDx (12) · Organon and Co (12)

What is being tested here

Drugs under test in Coronary Disease studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexmedetomidine203
Ticagrelor1210
Colchicine113
Vitamin K 1101
PCSK9 Inhibitor101
Thiamine101
Resveratrol101
Mazdutide101
Olpasiran111
Yangxinshi101

Drug classes tested here P2Y12 inhibitors 1 open · Statins 34 · NSAIDs 11 · ACE inhibitors 6 · Estrogens 4

Coming up

3phase 3 studies under way
53studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 106 Coronary Disease studies recruiting now, 64 (60%) set no upper age limit and 19 (18%) stop at 75 or younger. 8 (8%) take children under 18. 3 (3%) are for women only and 0 (0%) for men only; 10 (9%) take healthy volunteers.

Recruiting studies that take each age, of 106
AgeWomenMen
108 (8%)8 (8%)
1879 (75%)77 (73%)
3088 (83%)86 (81%)
4091 (86%)89 (84%)
5095 (90%)92 (87%)
6599 (93%)96 (91%)
7596 (91%)94 (89%)
8576 (72%)75 (71%)

Across all 1,520 studies, recruiting or not: 20% stop at 75 or younger and 6% at 65; 18% take children; 3% are for women only and 10% for men only; 11% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Coronary Disease studies take

Of 26 phase 4 interventional studies under Coronary Disease, half reached primary completion within 33 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 217 mo10–39 · 19 studies——
Phase 433 mo16–58 · 26 studies——
Interventional, no phase25 mo14–51 · 200 studies—26 mo15–51 · 178 studies
Observational47 mo21–123 · 154 studies—59 mo24–192 · 132 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 1,520. Browse all 1,520 → or search them.